AUM Pharmacy
Health Hub
Search Icon

AUM Pharmacy

Hi there!

Hello, Login
All Categories
VisaVisaVisa
fallback

Dybito MV 2mg/500mg/0.3mg Tablet

Prescription Icon
Prescription Required

Marketer

Avail Healthcare

Salt Composition

Glimepiride (2mg) + Metformin (500mg) + Voglibose (0.3mg)

Overview Dybito MV 2mg/500mg/0.3mg Tablet

Dybito MV 2mg/500mg/0.3mg tablets are classified as antidiabetic medications, a combination therapy for adult type 2 diabetes mellitus. This medication helps manage blood glucose levels. Administer Dybito MV with food, consistently at the same time daily for optimal efficacy. Dosage is determined by your physician and may be adjusted based on your blood sugar response. Continuous use is crucial; discontinuation without medical consultation risks elevated blood sugar, potentially leading to kidney complications, vision impairment, neuropathy, and limb loss. Remember, this medication complements a comprehensive diabetes management plan encompassing diet, exercise, and weight management as directed by your doctor. Lifestyle choices significantly impact diabetes control. Hypoglycemia (low blood sugar) is a prevalent side effect, characterized by sweating, dizziness, headache, and tremors. Regular meals and readily available glucose sources (e.g., sugary foods, fruit juice) are essential. Alcohol consumption increases hypoglycemia risk and should be avoided. Additional potential side effects include altered taste, nausea, diarrhea, abdominal discomfort, headache, edema, blurred vision, fractures, and upper respiratory infections. Weight gain is also possible. This medication is contraindicated in type 1 diabetes, diabetic ketoacidosis, and severe hepatic or renal impairment. Prior heart disease should be disclosed to your physician before commencing treatment. Pregnant or lactating individuals require medical consultation before use. Regular blood glucose monitoring and periodic blood tests (blood cell counts and liver function) are recommended.

Primary Ingredients of Dybito MV 2mg/500mg/0.3mg Tablet

No information provided. Therefore, no text can be rewritten.

Uses of Dybito MV 2mg/500mg/0.3mg Tablet

Managing type 2 diabetes

Major Benefits of Dybito MV 2mg/500mg/0.3mg Tablet:

Administer this medication precisely as prescribed by your physician, adhering to the specified dosage and treatment period. Ingest the Dybito MV 2mg/500mg/0.3mg tablet whole; do not chew, crush, or fracture it. Consumption should occur on an empty stomach.

Common Side effects of Dybito MV 2mg/500mg/0.3mg Tablet:

  • Nausea
  • Diarrhea
  • Abdominal pain
  • Hypoglycemia (low blood glucose level)
  • Loss of appetite

How to use Dybito MV 2mg/500mg/0.3mg Tablet:

Consume this medication precisely as directed by your physician, adhering to both the prescribed dosage and timeframe. Ingest the Dybito MV 2mg/500mg/0.3mg Tablet whole; avoid chewing, crushing, or fracturing it. Administer on an empty stomach.

How Dybito MV 2mg/500mg/0.3mg Tablet works:

Each Dybito MV tablet (2mg/500mg/0.3mg) combines three distinct antidiabetic agents.

SAFETY ADVICE

AlcoholAlcoholUNSAFE

Concurrent alcohol and Dybito MV 2mg/500mg/0.3mg Tablet ingestion is inadvisable.

PregnancyPregnancyCONSULT YOUR DOCTOR

The use of Dybito MV 2mg/500mg/0.3mg Tablet during pregnancy may pose risks. While human data is scarce, animal research indicates potential harm to a fetus. A physician will assess the potential advantages against the risks prior to prescribing. Consult your doctor for advice.

Breast feedingBreast feedingCONSULT YOUR DOCTOR

The use of Dybito MV 2mg/500mg/0.3mg tablets while breastfeeding is likely inadvisable. Preliminary human evidence indicates potential drug transfer via breast milk, posing a risk to the infant.

DrivingDrivingCAUTION

Driving ability can be impaired by both hypoglycemia and hyperglycemia. Refrain from driving if such symptoms arise.

KidneyKidneyUNSAFE

The use of Dybito MV 2mg/500mg/0.3mg tablets is likely inadvisable for individuals with impaired kidney function and should be omitted. Medical advice is recommended. Furthermore, this medication is not suggested for patients exhibiting severe kidney disease.

LiverLiverCAUTION

Patients with liver impairment should use Dybito MV 2mg/500mg/0.3mg tablets cautiously, potentially requiring dosage modification. A physician's consultation is advised. For those with mild to moderate liver disease, initiation should involve a reduced dose; the medication is contraindicated in cases of severe hepatic dysfunction.

What if you forget to take Dybito MV 2mg/500mg/0.3mg Tablet :

Should you forget to take your Dybito MV 2mg/500mg/0.3mg Tablet, administer it immediately upon remembrance. However, if your next scheduled dose is imminent, omit the missed dose and resume your usual dosing regimen. Avoid taking a double dose.

Facts to Know About Dybito MV 2mg/500mg/0.3mg Tablet

LabelValue
Developing Good Habits No.
Treatment Category Diabetes Management

FAQs on Dybito MV 2mg/500mg/0.3mg Tablet

Dybito MV 2mg/500mg/0.3mg Tablets combine glimepiride, metformin, and voglibose to manage type 2 diabetes mellitus (DM) in adults. This combination improves blood glucose control when used with diet and exercise. Glimepiride stimulates insulin release; metformin reduces liver glucose production and enhances insulin sensitivity; and voglibose, an alpha-glucosidase inhibitor, lowers postprandial glucose. This medication is unsuitable for type 1 DM.
Dybito MV 2mg/500mg/0.3mg Tablets may cause common side effects including low blood sugar (hypoglycemia), nausea, diarrhea, altered taste, gas, stomach pain, headache, skin rash, and respiratory infection.
Dybito MV 2mg/500mg/0.3mg Tablets are contraindicated in patients with allergies to any ingredient or excipient. Their use is also contraindicated in those with moderate to severe kidney disease, inflammatory bowel disease, colonic ulcerations, or underlying metabolic acidosis, including diabetic ketoacidosis.
Combining Dybito MV 2mg/500mg/0.3mg Tablet with alcohol is unsafe. This combination can cause dangerously low blood sugar (hypoglycemia) and raise the risk of lactic acidosis.
Dybito MV 2mg/500mg/0.3mg Tablets can cause low blood sugar (hypoglycemia), manifesting as nausea, headache, irritability, hunger, sweating, dizziness, rapid heartbeat, anxiety, or shakiness. This risk increases with missed meals, alcohol consumption, excessive exercise, or concurrent use of other antidiabetic medications. Therefore, regular blood sugar monitoring is crucial. Always carry a fast-acting sugar source, such as glucose tablets, honey, or fruit juice.
Store this medication in its original, tightly closed container as directed on the label. Discard any unused medication and keep it out of reach of children, pets, and others.
Dybito MV 2mg/500mg/0.3mg...
130
MRP 150
13% off